Stockscreener 앱 받기
9.93
1.53%
0.15
시간 외 거래:
10.45
0.52
+5.24%
Leonabio Inc 주식(LONA)의 최신 뉴스
LeonaBio, Inc. Adopts 2026 Equity Incentive Plan and Amends Certificate of Incorporation – SEC 8-K Filing March 2026 - Minichart
LeonaBio shareholders approve equity plan and increase in authorized shares - Investing.com
LeonaBio Expands Share Authorization to Support Future Financing - TipRanks
LeonaBio (ATHA) wins approval for 2026 equity plan and major share increase - Stock Titan
LONA: LeonaBio, Inc.Options Chain - Zacks Investment Research
LeonaBio, Inc. (prev. ATHA) (LONA) Stock Price Prediction for 2026, 2030-2040 - Traders Union
[DEFR14A] LeonaBio, Inc. Revised Proxy Statement - Stock Titan
Renninger, LeonaBio CFO, sells $4.9k in LONA stock - Investing.com Nigeria
LeonaBio CEO Litton sells $27,687 in shares By Investing.com - Investing.com UK
LeonaBio CEO Litton sells $27,687 in shares - Investing.com South Africa
Renninger, LeonaBio CFO, sells $4.9k in LONA stock By Investing.com - Investing.com Canada
LeonaBio (ATHA) CEO converts 22,254 RSUs and sells shares for taxes - Stock Titan
LeonaBio (LONA) CMO covers RSU tax bill with share sale - Stock Titan
LeonaBio (NASDAQ: ATHA) files to sell 22,254 shares after RSU lapse - Stock Titan
Athira Pharma (LONA) 10K Form and SEC Filings 2026 $LONA - MarketBeat
Cantor Fitzgerald initiates Leona Bio stock with overweight rating By Investing.com - Investing.com Australia
LeonaBio initiated with an Overweight at Cantor Fitzgerald - TipRanks
Cantor Fitzgerald Initiates Coverage on LeonaBio With Overweight Rating - marketscreener.com
Cantor Fitzgerald initiates Leona Bio stock with overweight rating - Investing.com UK
LONA Technical Analysis & Stock Price Forecast - Intellectia AI
LONA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
LeonaBio Inc expected to post a loss of 85 cents a shareEarnings Preview - TradingView
LeonaBio, Inc. (prev. ATHA) (LONA) Stock Price Today | Live Chart & News - Traders Union
LeonaBio Shares Rise After Mizuho Securities Upgrade - marketscreener.com
LeonaBio (LONA) Receives Upgrade to Outperform by Mizuho | LONA Stock News - GuruFocus
Mizuho upgrades LeonaBio stock rating on breast cancer drug potential By Investing.com - Investing.com South Africa
Mizuho upgrades LeonaBio stock rating on breast cancer drug potential - Investing.com
Mizuho Securities Initiates LeonaBio(LONA.US) With Buy Rating, Announces Target Price $10 - 富途牛牛
LeonaBio (ATHA) proxy asks investors to back warrant share issuances and 2026 equity plan - stocktitan.net
LeonaBio appoints Mark Kubik as chief business officer By Investing.com - Investing.com Nigeria
Leonabio, Inc. Announces the Appointment of Mark F. Kubik as Chief Business Officer - marketscreener.com
LeonaBio (LONA) Names Mark Kubik as New Chief Business Officer - GuruFocus
LeonaBio appoints Mark Kubik as chief business officer - Investing.com
LeonaBio, Inc. Appoints Mark F. Kubik as Chief Business Officer to Drive Business Development Strategy - Quiver Quantitative
LeonaBio Appoints Industry Veteran Mark F. Kubik as Chief Business Officer - marketscreener.com
Biopharma deal veteran to drive LeonaBio’s Phase 3 breast cancer drug - Stock Titan
Leonabio Inc files for offering of up to 58.5 million shares of common stock by the selling stockholders - marketscreener.com
Leonabio Inc Files For Offering Of Up To 58.5 Million Shares Of Common Stock By The Selling Stockholders - TradingView
symbol__ Stock Quote Price and Forecast - CNN
Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker "LONA" - Investing News Network
LONA Stock Price and Chart — NASDAQ:LONA - TradingView
Athira Pharma (ATHA) Options to Be Delisted on January 12th - GuruFocus
LONA Stock Price, News & Analysis - Stock Titan
Athira Pharma Rebrands as LeonaBio, Refocusing on Oncology - TipRanks
Athira Pharma announces name change to LeonaBio - TipRanks
Athira Pharma roars into the new year with rebrand to LeonaBio - Fierce Pharma
Athira Pharma changes name, ticker symbol - MSN
Athira Pharma rebrands as LeonaBio amid strategic pivot to cancer therapy - Investing.com Nigeria
1.20%
0.06%
자본화:
|
볼륨(24시간):